DOCSLIB.ORG

(QUEENIE) CHEONG, BS Submitted in Partial

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(QUEENIE) CHEONG, BS Submitted in Partial MOLECULAR AND PHYSIOLOGICAL RESPONSES TO HYPOXIA by HOI I (QUEENIE) CHEONG, B.S. Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Molecular Medicine CASE WESTERN RESERVE UNIVERSITY May, 2017 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/ dissertation of Hoi I (Queenie) Cheong Candidate for the degree of Ph.D. Committee Chair Kingman P. Strohl, M.D. Committee Members Mitchell Drumm, Ph.D. George R. Stark, Ph.D. Sathyamangla V. Naga Prasad, Ph.D. Serpil C. Erzurum, M.D. (Thesis Advisor) Date of Defense February 27th, 2017 * We also certify that written approval has been obtained for any proprietary material contained therein. DEDICATION To my parents, Lai Wa Lam and Kuok Kin Cheong. For they are the reason for whom I have become today. For their strength and love to support me to leave home since 2003 to broaden my vision and knowledge. To my mentor, Serpil C. Erzurum. For providing such wonderful learning opportunities and experience for science, medicine, collaborative spirits and leadership. To my husband, Emir Charles Roach. For his continuous love and kind support. For his intellectual curiosity to stir daily scientific discussions. For his excitements and encouragements. Table of Contents List of Tables iii List of Figures iv Acknowledgements vi List of Abbreviations viii Abstract ix Chapters 1. Introduction I. Hypoxia 1 II. HIF-1 in Hypoxia Sensing Ø History of discovery 1 Ø Function 2 Ø Regulation 3 III. Beta-Adrenergic Receptors and Hypoxia Responses Ø βAR subtypes, expression, structure and history 4 Ø Ligand binding 5 Ø β2AR signaling 5 Ø βAR function 6 Ø βAR under hypoxia 8 IV. Nitric Oxide: an Adaptive Response at High Altitude Ø Background 10 Ø Sources of nitric oxide 10 Ø Mechanism of Action 12 Ø Nitric Oxide at High Altitude 13 i 2. Hypoxia Sensing through Beta-Adrenergic Receptors Ø Abstract 15 Ø Introduction 16 Ø Results 19 Ø Figures 25 Ø Tables 34 Ø Supplemental Tables 35 Ø Discussion 38 3. Alternative Hematological and Vascular Adaptive Responses to High-Altitude Hypoxia in East African Highlanders Ø Abstract 55 Ø Introduction 56 Ø Materials and Methods 58 Ø Results 61 Ø Figures 65 Ø Discussion 70 4. Discussion and Future Directions Ø A novel role of βAR in hypoxia sensing 76 Ø Does hypoxia induce GRK activity? 76 Ø Is β-arrestin the molecular that mechanistically link GRK and HIF-1? 78 Ø Translational aspects of GRK in pulmonary arterial hypertension 78 Ø Nitric oxide-mediated flow based pathway as an alternative hypoxia response to erythropoiesis 80 Ø What is/ are the potential mechanism(s) of higher hemoglobin affinity with hypoxic adaptation? 81 Bibliography 83 ii List of Tables Table 1. Quantitative analyses of β2AR phosphorylation sites 34 Supplemental Table 1. Examples of hypoxia-inducible genes, whose expression levels are reversed by propranolol 35 Supplemental Table 2. KEGG pathway analysis of transcripts reversed by propranolol under hypoxia 36 Supplemental Table 3. Percent phosphorylation of β2AR sites at 21% or 2% oxygen, or with isoproterenol (ISO) 37 iii List of Figures Chapter 2 Figure 1. β-Blocker blunts HIF-mediated erythropoiesis under hypoxia in vivo. 25 Figure 2. β-Blocker attenuates hypoxia responses in vitro. 26 Figure 3. β-Agonist promotes HIF-1α accumulation under normoxia. 28 Figure 4. Hypoxia or β-agonist mediated HIF-1a accumulation depends on phosphorylation of beta-adrenergic receptor (βAR) by G protein-coupled receptor kinase (GRK). 29 Figure 5. Hypoxia induces a unique beta-adrenergic receptor (βAR) phosphorylation barcode in the absence of agonist binding. 31 Figure 6. Working Model. 33 Chapter 3 − Figure 1. Elevated urinary levels of nitrate (NO3 ) and cyclic guanosine monophosphate (cGMP) in high-altitude Amhara but not Oromo. 65 − Figure 2. Higher NO3 level is associated with higher cGMP in urine samples of Amhara and Oromo. 66 Figure 3. Diastolic blood pressures of Amhara were lower than Oromo at high altitudes. 67 iv Figure 4. Oxygen-saturated hemoglobin levels do not change with altitudes in Amhara and Oromo, whereas the increase in deoxyhemoglobin from low to high altitude is much greater in Oromo than Amhara. 68 Fig. 5. Increased affinity of hemoglobin for oxygen in high-altitude samples, relative to hypothetical subjects derived from the standard oxygen dissociation curve (ODC). 69 v Acknowledgements July 2011 marked the beginning of my Ph.D. training. The first year of coursework was a well-planned curriculum by the Molecular Medicine Ph.D. program, directed by Jonathan Smith, Ph.D. and administered by Marcia Jarrett, Ph.D. Robert Fairchild, Ph.D. has also been very supportive of students. I would like to thank them for nurturing students’ growth. I would also like to thank the faculty who has taught the classes, and the Howard Hughes Medical Institute who has conceptualized the Med-into-Grad Initiative and funded this program to make the training possible. In July 2012, I started my thesis with the mentorship of Serpil C. Erzurum, M.D., who has been instrumental in guiding my development, both in research and career. I sincerely thank Dr. Erzurum for providing many opportunities to grow inside and outside of lab, and for continuously encouraging me to explore and pursue my interests. I am very grateful to my thesis committee, composed of Kingman Strohl, M.D., Raed Dweik, M.D., Mitchell Drumm, Ph.D., George R. Stark, Ph.D. and Sathyamangla V. Naga Prasad, Ph.D. Throughout the years, they have provided valuable advice on research, writing and oral presentation skills, which serve as the foundation for my career. The inception of the project “hypoxia sensing through beta- adrenergic receptors” was based on the work of Weiling Xu, M.D. on vi pulmonary hypertension. I thank Weiling for orienting me in the lab in the very beginning and for training me different techniques, which enable me to take the project to the next level. Other lab members, including Adrianna Garchar, Olivia Stephens, Kewal Asosingh, Ph.D., Kimberly Queisser, Suzy Comhair, Ph.D. and Lori Mavrakis have been very supportive throughout my training. The high altitude adaptation project would not have been possible without the guidance of Cynthia Beall, Ph.D. and Allison Janocha. They were the people in the field in East Africa, and had shared valuable insights and experience with me. Lastly, there are sincere and true friendships cultivated throughout the years that made me strong and feel supported. Thank you very much, Marybeth Boyle, Francis Enane and Josephine Dermawan! vii List of Abbreviations HIF-1, Hypoxia Inducible Factor-1 βAR, beta-adrenergic receptors cGMP, cyclic guanosine monophosphate cAMP, cyclic adenosine monophosphate PKA, protein kinase A GRK, G protein-coupled receptor kinases - NO3 , nitrate NO, nitric oxide VHL, von Hippel-Lindau ODDD, oxygen-dependent degradation domain CAD, COOH-terminal transactivation domain RACK1, Receptors for activated C-kinase NOS, nitric oxide synthases 2,3-DPG, 2,3-diphosphoglyceric acid OSC, oxygen saturation curve viii Molecular and Physiological Responses to Hypoxia Abstract by HOI I (QUEENIE) CHEONG Life-sustaining responses to hypoxia rely on the transcription factor, Hypoxia Inducible Factor-1 (HIF-1). Under hypoxia, HIF-1 accumulates and regulates multifaceted cellular responses. However, many underlying mechanisms of HIF-1 regulation are incompletely understood. Previous studies suggest a link between HIF-1 and beta-adrenergic receptors (βAR). Here, we interrogated the role of βARs in hypoxia responses by β- blocker treatment of mice with hypoxia-inducible erythropoiesis. β-blocker suppressed renal accumulation of HIF-1α, erythropoietin production and the generation of erythroid progenitor cells. Likewise, β-blocker treatment of human endothelial cells attenuated HIF-1α accumulation and binding to target genes under hypoxia, and subsequent downstream gene expression. Consistently, β-agonist increased HIF-1α accumulation in a dose- and time-dependent manner, an effect that was blocked by both β1- and β2-blockers, indicating a general property of this receptor class. βAR signal transduction involves cyclic adenosine monophosphate (cAMP)-activated protein kinase A (PKA) and G protein-coupled receptor kinases (GRK). Direct activation of cAMP/ PKA pathways did not increase ix HIF-1α accumulation, and inhibition of PKA did not suppress HIF-1α by hypoxia. In contrast, pharmacological inhibition of GRK, or genetic mutation of βAR that impairs GRK phosphorylation, blocked hypoxia- mediated HIF-1α accumulation. Mass spectrometry analyses revealed a unique hypoxia βAR phosphorylation barcode different from the classical agonist. These findings identify an unknown role of βAR in hypoxia responses. Another determinant of HIF-1 regulation is nitric oxide, a potent vasodilator. A natural experiment of genetically similar Ethiopians at high altitude (>3000 m), the Amhara and Oromo, revealed a dampened hemoglobin response in Amhara compared to Oromo. We hypothesized that Amhara highlanders offset their dampened hemoglobin response with the vascular nitric oxide response. We identified high levels of urinary nitrate and its bioactive signal molecule cyclic guanosine monophosphate (cGMP) in high-altitude Amhara, but not Oromo. Consistently, high-altitude Amhara have lower diastolic blood pressure than Oromo, an indicator of vasomotor tone. Both Amhara and Oromo maintained the amount of oxyhemoglobin at high altitudes, but the high-altitude Oromo suffered a much higher deoxyhemoglobin level. In conclusion, high-altitude Amhara offset a dampened hemoglobin response with the vasodilatory nitric oxide, whereas the Oromo mount a bigger hemoglobin response at the cost of circulating deoxyhemoglobin. x Chapter 1 Introduction I. Hypoxia Hypoxia is low oxygen. There are two major ways of experiencing hypoxia, acute and chronic hypoxia exposure. An example of acute hypoxia is rapid ascent to high altitude. One can imagine mountaineers that climb the Mount Everest. An example of chronic hypoxia is lifelong residence at high altitude, such as the Tibetan highlanders.
Load more

Recommended publications
  • Supplemental Table S1
    Entrez Gene Symbol Gene Name Affymetrix EST Glomchip SAGE Stanford Literature HPA confirmed Gene ID Profiling profiling Profiling Profiling array profiling confirmed 1 2 A2M alpha-2-macroglobulin 0 0 0 1 0 2 10347 ABCA7 ATP-binding cassette, sub-family A (ABC1), member 7 1 0 0 0 0 3 10350 ABCA9 ATP-binding cassette, sub-family A (ABC1), member 9 1 0 0 0 0 4 10057 ABCC5 ATP-binding cassette, sub-family C (CFTR/MRP), member 5 1 0 0 0 0 5 10060 ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9 1 0 0 0 0 6 79575 ABHD8 abhydrolase domain containing 8 1 0 0 0 0 7 51225 ABI3 ABI gene family, member 3 1 0 1 0 0 8 29 ABR active BCR-related gene 1 0 0 0 0 9 25841 ABTB2 ankyrin repeat and BTB (POZ) domain containing 2 1 0 1 0 0 10 30 ACAA1 acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3-oxoacyl-Coenzyme A thiol 0 1 0 0 0 11 43 ACHE acetylcholinesterase (Yt blood group) 1 0 0 0 0 12 58 ACTA1 actin, alpha 1, skeletal muscle 0 1 0 0 0 13 60 ACTB actin, beta 01000 1 14 71 ACTG1 actin, gamma 1 0 1 0 0 0 15 81 ACTN4 actinin, alpha 4 0 0 1 1 1 10700177 16 10096 ACTR3 ARP3 actin-related protein 3 homolog (yeast) 0 1 0 0 0 17 94 ACVRL1 activin A receptor type II-like 1 1 0 1 0 0 18 8038 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 1 0 0 0 0 19 8751 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 1 0 0 0 0 20 8728 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 1 0 0 0 0 21 81792 ADAMTS12 ADAM metallopeptidase with thrombospondin type 1 motif, 12 1 0 0 0 0 22 9507 ADAMTS4 ADAM metallopeptidase with thrombospondin type 1
    [Show full text]
  • Beta-Arrestin-Mediated Signaling in the Heart
    SPECIAL ARTICLE Circ J 2008; 72: 1725–1729 Beta-Arrestin-Mediated Signaling in the Heart Priyesh A. Patel, BS; Douglas G. Tilley, PhD*; Howard A. Rockman, MD*,** Beta-arrestin is a multifunctional adapter protein well known for its role in G-protein-coupled receptor (GPCR) desensitization. Exciting new evidence indicates thatβ-arrestin is also a signaling molecule capable of initiating its own G-protein-independent signaling at GPCRs. One of the best-studiedβ-arrestin signaling pathways is the one involvingβ-arrestin-dependent activation of a mitogen-activated protein kinase cascade, the extracellular regulated kinase (ERK). ERK signaling, which is classically activated by agonist stimulation of the epidermal growth factor receptor (EGFR), can be activated by a number of GPCRs in aβ-arrestin-dependent manner. Recent work in animal models of heart failure suggests thatβ-arrestin-dependent activation of EGFR/ERK signaling by theβ-1-adrenergic receptor, and possibly the angiotensin II Type 1A receptor, are cardioprotective. Hence, a new model of signaling at cardiac GPCRs has emerged and implicates classical G-protein-mediated signaling with promoting harmful remodeling in heart failure, while concurrently linkingβ-arrestin-dependent, G-protein-inde- pendent signaling with cardioprotective effects. Based on this paradigm, a new class of drugs could be identified, termed “biased ligands”, which simultaneously block harmful G-protein signaling, while also promoting cardio- protectiveβ-arrestin-dependent signaling, leading to a potential breakthrough
    [Show full text]
  • BMC Evolutionary Biology Biomed Central
    BMC Evolutionary Biology BioMed Central Research article Open Access On the origins of arrestin and rhodopsin Carlos E Alvarez1,2,3 Address: 1Center for Molecular and Human Genetics, The Research Institute at Nationwide Children's Hospital, Columbus, OH, 43205, USA, 2Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, 43210, USA and 3Novartis Institutes of BioMedical Research, CH-4002 Basel, Switzerland Email: Carlos E Alvarez - [email protected] Published: 29 July 2008 Received: 11 January 2008 Accepted: 29 July 2008 BMC Evolutionary Biology 2008, 8:222 doi:10.1186/1471-2148-8-222 This article is available from: http://www.biomedcentral.com/1471-2148/8/222 © 2008 Alvarez; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: G protein coupled receptors (GPCRs) are the most numerous proteins in mammalian genomes, and the most common targets of clinical drugs. However, their evolution remains enigmatic. GPCRs are intimately associated with trimeric G proteins, G protein receptor kinases, and arrestins. We conducted phylogenetic studies to reconstruct the history of arrestins. Those findings, in turn, led us to investigate the origin of the photosensory GPCR rhodopsin. Results: We found that the arrestin clan is comprised of the Spo0M protein family in archaea and bacteria, and the arrestin and Vps26 families in eukaryotes. The previously known animal arrestins are members of the visual/beta subfamily, which branched from the founding "alpha" arrestins relatively recently.
    [Show full text]
  • Role and Regulation of Pdgfra Signaling in Liver Development and Regeneration
    The American Journal of Pathology, Vol. 182, No. 5, May 2013 ajp.amjpathol.org GROWTH FACTORS, CYTOKINES, AND CELL CYCLE MOLECULES Role and Regulation of PDGFRa Signaling in Liver Development and Regeneration Prince K. Awuah,* Kari N. Nejak-Bowen,* and Satdarshan P.S. Monga*y From the Division of Experimental Pathology,* Department of Pathology, and the Department of Medicine,y University of Pittsburgh, Pittsburgh, Pennsylvania Accepted for publication January 22, 2013. Aberrant platelet-derived growth factor receptor-a (PDGFRa) signaling is evident in a subset of hepato- cellular cancers (HCCs). However, its role and regulation in hepatic physiology remains elusive. In the Address correspondence to a fi Satdarshan P.S. Monga, M.D., current study, we examined PDGFR signaling in liver development and regeneration. We identi ed a a Divisions of Experimental notable PDGFR activation in hepatic morphogenesis that, when interrupted by PDGFR -blocking anti- Pathology, Pathology and body, led to decreased hepatoblast proliferation and survival in embryonic liver cultures. We also identified Medicine, University of Pitts- temporal PDGFRa overexpression, which is regulated by epidermal growth factor (EGF) and tumor necrosis burgh School of Medicine, 200 factor a, and its activation at 3 to 24 hours after partial hepatectomy. Through generation of hepatocyte- Lothrop St., S-422 BST, Pitts- specific PDGFRA knockout (KO) mice that lack an overt phenotype, we show that absent PDGFRa burgh, PA 15261. E-mail: compromises extracelluar signal-regulated kinases and AKT activation 3 hours after partial hepatectomy, [email protected]. which, however, is alleviated by temporal compensatory increases in the EGF receptor (EGFR) and the hepatocyte growth factor receptor (Met) expression and activation along with rebound activation of extracellular signal-regulated kinases and AKT at 24 hours.
    [Show full text]
  • Gene and Pathway-Based Second-Wave Analysis of Genome-Wide Association Studies
    European Journal of Human Genetics (2010) 18, 111–117 & 2010 Macmillan Publishers Limited All rights reserved 1018-4813/10 $32.00 www.nature.com/ejhg ARTICLE Gene and pathway-based second-wave analysis of genome-wide association studies Gang Peng1, Li Luo2, Hoicheong Siu1, Yun Zhu1, Pengfei Hu1, Shengjun Hong1, Jinying Zhao3, Xiaodong Zhou4, John D Reveille4, Li Jin1, Christopher I Amos5 and Momiao Xiong*,2 Despite the great success of genome-wide association studies (GWAS) in identification of the common genetic variants associated with complex diseases, the current GWAS have focused on single-SNP analysis. However, single-SNP analysis often identifies only a few of the most significant SNPs that account for a small proportion of the genetic variants and offers only a limited understanding of complex diseases. To overcome these limitations, we propose gene and pathway-based association analysis as a new paradigm for GWAS. As a proof of concept, we performed a comprehensive gene and pathway-based association analysis of 13 published GWAS. Our results showed that the proposed new paradigm for GWAS not only identified the genes that include significant SNPs found by single-SNP analysis, but also detected new genes in which each single SNP conferred a small disease risk; however, their joint actions were implicated in the development of diseases. The results also showed that the new paradigm for GWAS was able to identify biologically meaningful pathways associated with the diseases, which were confirmed by a gene-set-rich analysis using gene expression
    [Show full text]
  • 140503 IPF Signatures Supplement Withfigs Thorax
    Supplementary material for Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis Daryle J. DePianto1*, Sanjay Chandriani1⌘*, Alexander R. Abbas1, Guiquan Jia1, Elsa N. N’Diaye1, Patrick Caplazi1, Steven E. Kauder1, Sabyasachi Biswas1, Satyajit K. Karnik1#, Connie Ha1, Zora Modrusan1, Michael A. Matthay2, Jasleen Kukreja3, Harold R. Collard2, Jackson G. Egen1, Paul J. Wolters2§, and Joseph R. Arron1§ 1Genentech Research and Early Development, South San Francisco, CA 2Department of Medicine, University of California, San Francisco, CA 3Department of Surgery, University of California, San Francisco, CA ⌘Current address: Novartis Institutes for Biomedical Research, Emeryville, CA. #Current address: Gilead Sciences, Foster City, CA. *DJD and SC contributed equally to this manuscript §PJW and JRA co-directed this project Address correspondence to Paul J. Wolters, MD University of California, San Francisco Department of Medicine Box 0111 San Francisco, CA 94143-0111 [email protected] or Joseph R. Arron, MD, PhD Genentech, Inc. MS 231C 1 DNA Way South San Francisco, CA 94080 [email protected] 1 METHODS Human lung tissue samples Tissues were obtained at UCSF from clinical samples from IPF patients at the time of biopsy or lung transplantation. All patients were seen at UCSF and the diagnosis of IPF was established through multidisciplinary review of clinical, radiological, and pathological data according to criteria established by the consensus classification of the American Thoracic Society (ATS) and European Respiratory Society (ERS), Japanese Respiratory Society (JRS), and the Latin American Thoracic Association (ALAT) (ref. 5 in main text). Non-diseased normal lung tissues were procured from lungs not used by the Northern California Transplant Donor Network.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • PDGF-C and PDGF-D Signaling in Vascular Diseases and Animal Models
    Molecular Aspects of Medicine 62 (2018) 1e11 Contents lists available at ScienceDirect Molecular Aspects of Medicine journal homepage: www.elsevier.com/locate/mam PDGF-C and PDGF-D signaling in vascular diseases and animal models * Erika Folestad a, Anne Kunath b, Dick Wågsater€ b, a Division of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden b Division of Drug Research, Department of Medical and Health Sciences, Linkoping€ University, Linkoping,€ Sweden article info abstract Article history: Members of the platelet-derived growth factor (PDGF) family are well known to be involved in different Received 31 August 2017 pathological conditions. The cellular and molecular mechanisms induced by the PDGF signaling have Received in revised form been well studied. Nevertheless, there is much more to discover about their functions and some 14 November 2017 important questions to be answered. This review summarizes the known roles of two of the PDGFs, Accepted 22 January 2018 PDGF-C and PDGF-D, in vascular diseases. There are clear implications for these growth factors in several Available online 14 February 2018 vascular diseases, such as atherosclerosis and stroke. The PDGF receptors are broadly expressed in the cardiovascular system in cells such as fibroblasts, smooth muscle cells and pericytes. Altered expression Keywords: Aneurysm of the receptors and the ligands have been found in various cardiovascular diseases and current studies fi Atherosclerosis have shown important implications of PDGF-C and PDGF-D signaling in brosis, neovascularization, Growth factor atherosclerosis and restenosis. Myocardial infarction © 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND Smooth muscle cells license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
    [Show full text]
  • Erzurum CV.Pdf
    CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE OF CASE WESTERN RESERVE UNIVERSITY PERSONAL INFORMATION Name: Erzurum, Serpil C. Date of Birth: February 13, 1959 Place of Birth: Cleveland, Ohio Citizenship: USA Education School: Youngstown State University, Youngstown, Ohio Degree: Bachelor of Science Dates: 1977-1979 School: Northeastern Ohio Universities College of Medicine, Rootstown, Ohio Degree: Doctor of Medicine Dates: 1979-1983 Post-Graduate Training Institution: Baylor College of Medicine, Houston, TX Position: Internship/Residency – Internal Medicine Dates: 1983-1986 Institution: University of Colorado Health Sciences Center, Denver, CO Position: Fellowship – Pulmonary/Critical Care Dates: 1987-1990 Institution: National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD Position: Senior Staff Fellow Dates: 1990-1992 Institution: Cleveland Clinic, Cleveland, OH Position: Leading in Health Care Postgraduate Program, Office of Professional Staff Affairs and the Office of Practice Management Dates: 2006-2007 Contact Information Institution/Institute/Department: Cleveland Clinic/Lerner Research Institute Office Address: 9500 Euclid Avenue, Cleveland, Ohio, 44195-0001 Office Mail Code: NB21 Office Phone: 216-445-6624 Beeper: 216-444-4000 x 24861 Office E-mail: [email protected] Facsimile: 216-444-3279 PROFESSIONAL APPOINTMENTS Position/Rank: Chair Institution: Cleveland Clinic Health System Institute: Lerner Research Institute Dates: 2016-Present Position/Rank: Chair Institution: Cleveland Clinic Institute: Lerner
    [Show full text]
  • Ep 3217179 A1
    (19) TZZ¥ ___T (11) EP 3 217 179 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 13.09.2017 Bulletin 2017/37 G01N 33/68 (2006.01) (21) Application number: 17167637.2 (22) Date of filing: 02.10.2013 (84) Designated Contracting States: • LIU, Xinjun AL AT BE BG CH CY CZ DE DK EE ES FI FR GB San Diego, CA 92130 (US) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • HAUENSTEIN, Scott PL PT RO RS SE SI SK SM TR San Diego, CA 92130 (US) • KIRKLAND, Richard (30) Priority: 05.10.2012 US 201261710491 P San Diego, CA 92111 (US) 17.05.2013 US 201361824959 P (74) Representative: Krishnan, Sri (62) Document number(s) of the earlier application(s) in Nestec S.A. accordance with Art. 76 EPC: Centre de Recherche Nestlé 13779638.9 / 2 904 405 Vers-chez-les-Blanc Case Postale 44 (71) Applicant: Nestec S.A. 1000 Lausanne 26 (CH) 1800 Vevey (CH) Remarks: (72) Inventors: This application was filed on 21-04-2017 as a • SINGH, Sharat divisional application to the application mentioned Rancho Santa Fe, CA 92127 (US) under INID code 62. (54) METHODS FOR PREDICTING AND MONITORING MUCOSAL HEALING (57) The present invention provides methods for pre- an individual with a disease such as IBD. Information on dicting the likelihood of mucosal healing in an individual mucosal healing status derived from the use of the with a disease such as inflammatory bowel disease present invention can also aid in optimizing therapy (IBD).
    [Show full text]
  • 1 Curriculum Vitae of MELVYN C. GOLDSTEIN (Revised 4-6-2020)
    Curriculum Vitae Of MELVYN C. GOLDSTEIN (Revised 4-6-2020) Personal Background Education B.A., 1959, University of Michigan, history M.A., 1960, University of Michigan, history Ph.D. 1968, University of WAshington, anthropology Employment 1991-present: John Reynolds HArkness Professor of Anthropology, Case Western Reserve University 1991-present: Professor of International HeAlth, School of Medicine, Case Western Reserve University (secondary appointment) 1991-present: Co-Director, Center for ReseArch on Tibet, Case Western Reserve University 1987-1991: Director, Center for ReseArch on Tibet, Case Western Reserve University 1975-2002: ChairmAn of Department of Anthropology, Case Western Reserve University 1978-present: Professor of Anthropology, Case Western Reserve University 1974-1978: AssociAte Professor of Anthropology, Case Western Reserve University 1968-1971: AssistAnt Professor of Anthropology, Case Western Reserve University 1 -- Professional Activities and Honors Distinguished University Professor, Case Western Reserve University, 2020. Elected Member, National Academy of Sciences, Section 51, Anthropology, 2009- present. Distinguished Research Award, Case Western Reserve University, 2016 The AssociAtion for AsiAn Studies’ Joseph Levenson Prize for best monograph on Twentieth-Century China in 1989: Honorable Mention: ("A History of Modern Tibet, 1913-51: The Demise of the LAmAist StAte"). This monumental study is a path-breaking contribution to our understanding of modern Tibet. Melvyn Goldstein has marshalled an impressive array of documentary, archival and interview sources to provide critical new insights into the political and diplomatic history of Tibet during its independence of Chinese domination. Particularly important is the author’s use of Tibetan sources to go beyond the question of Tibet’s relation to China, and narrate in detail the conflicts within Tibetan society: between monastic and lay elements, between reformers and conservatives, between rival regents’ cliques.
    [Show full text]
  • Trust and Confidence at the Interfaces of the Life Sciences and Society: Does the Public Trust Science? a Workshop Summary
    THE NATIONAL ACADEMIES PRESS This PDF is available at http://www.nap.edu/21798 SHARE Trust and Confidence at the Interfaces of the Life Sciences and Society: Does the Public Trust Science? A Workshop Summary DETAILS 66 pages | 8.5 x 11 | PAPERBACK | ISBN 978-0-309-37792-8 AUTHORS BUY THIS BOOK Helaine E. Resnick, Keegan Sawyer, and Nancy Huddleston, Rapporteur; Roundtable on Public Interfaces of the Life Sciences; Board on Life Sciences; Division on Earth and Life Studies; Board on FIND RELATED TITLES Science Education; Division of Behavioral and Social Sciences and Education; National Academies of Sciences, Engineering, and Medicine Visit the National Academies Press at NAP.edu and login or register to get: – Access to free PDF downloads of thousands of scientific reports – 10% off the price of print titles – Email or social media notifications of new titles related to your interests – Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. (Request Permission) Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Copyright © National Academy of Sciences. All rights reserved. Trust and Confidence at the Interfaces of the Life Sciences and Society: Does the Public Trust Science? A Workshop Summary Helaine E. Resnick, Keegan Sawyer, and Nancy Huddleston, Rapporteurs Roundtable on Public Interfaces of the Life Sciences Board on Life Sciences Division on Earth and Life Studies Board on Science Education Division of Behavioral and Social Sciences and Education THE NATIONAL ACADEMIES PRESS Washington, DC www.nap.edu Copyright © National Academy of Sciences.
    [Show full text]